San Diego, CA -- (SBWIRE) -- 07/06/2016 -- An investigation on behalf of investors in shares of American Renal Associates Holdings Inc (NYSE:ARA) was announced over potential breaches of fiduciary duties by certain directors at American Renal Associates Holdings.

Investors who purchased shares of American Renal Associates Holdings Inc (NYSE:ARA) and currently hold any of those NYSE:ARA shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call 858-779-1554.

The investigation by a law firm concerns whether certain American Renal Associates Holdings directors breached their fiduciary duties and caused damage to the company and its shareholders.

Beverly, MA based American Renal Associates Holdings, Inc. is a dialysis services provider in the United States. American Renal Associates Holdings Inc went public in April 2016. Shares of American Renal Associates Holdings Inc (NYSE:ARA) grew from $27.06 per share in May 2016 to as high as $29.21 per share in June 2016. On July 1, 2016 it was reported that UnitedHealth Group Inc. sued American Renal Associates Holdings Inc. accusing it of fraud.

On July 5, 2016, NYSE:ARA shares closed at $25.71 per share.

Those who purchased shares of American Renal Associates Holdings Inc have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com